Showing results (211-220 of 264) with videos related to

Sort By:
Pageof 27
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 5, 2021
Selective hippocampal subfield volume reductions in World Trade Center responders with cognitive impairmentYael Deri, Sean A P Clouston, Christine DeLorenzo, et al.
JAMA Network Open|January 16, 2019
Association of the Haptoglobin Gene Polymorphism With Cognitive Function and Decline in Elderly African American Adults With Type 2 Diabetes: Findings From the Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) StudyMichal S Beeri, Hung-Mo Lin, Mary Sano, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 16, 2019
A randomized clinical trial to evaluate home-based assessment of people over 75 years oldMary Sano, Carolyn W Zhu, Jeffrey Kaye, et al.
World Journal of Nuclear Medicine|November 18, 2022
Assessment of Alzheimer's Disease Imaging Biomarkers in World Trade Center Responders with Cognitive Impairment at MidlifeMinos Kritikos, Ana M Franceschi, Paul Vaska, et al.
International Psychogeriatrics|October 15, 2014
Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definitionJeffrey Cummings, Jacobo Mintzer, Henry Brodaty, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 23, 2020
Reduced cortical thickness in World Trade Center responders with cognitive impairmentSean A P Clouston, Yael Deri, Megan Horton, et al.
Plos One|March 26, 2021
Transient changes in white matter microstructure during general anesthesiaCheuk Y Tang, Victoria X Wang, Min Yin Lun, et al.
Neurology|April 7, 2017
A phase 3 trial of IV immunoglobulin for Alzheimer diseaseNorman R Relkin, Ronald G Thomas, Robert A Rissman, et al.
The American Journal of Psychiatry|May 17, 2011
Cognitive effects of atypical antipsychotic medications in patients with Alzheimer's disease: outcomes from CATIE-ADCheryl L P Vigen, Wendy J Mack, Richard S E Keefe, et al.
Neuroscience Letters|January 19, 2023
BCI-838, an orally active mGluR2/3 receptor antagonist pro-drug, rescues learning behavior deficits in the PS19 MAPTP301S mouse model of tauopathyGeorgina Perez-Garcia, Mesude Bicak, Jean-Vianney Haure-Mirande, et al.
Pageof 27